• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase.川崎病:意大利儿科学会指南,第一部分-定义、流行病学、病因发病机制、急性期临床表现和治疗。
Ital J Pediatr. 2018 Aug 30;44(1):102. doi: 10.1186/s13052-018-0536-3.
2
Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks.川崎病:意大利儿科学会指南,第二部分——抵抗形式和心血管并发症的治疗、随访、生活方式和心血管风险预防。
Ital J Pediatr. 2018 Aug 30;44(1):103. doi: 10.1186/s13052-018-0529-2.
3
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease.意大利儿科学会关于川崎病一般治疗的修订建议。
Ital J Pediatr. 2021 Jan 25;47(1):16. doi: 10.1186/s13052-021-00962-4.
4
What paediatricians need to know about the updated 2017 American Heart Association Kawasaki disease guideline.儿科医生需要了解的2017年美国心脏协会川崎病指南更新内容。
Arch Dis Child. 2020 Jan;105(1):10-12. doi: 10.1136/archdischild-2018-315069. Epub 2019 Jul 3.
5
The Complexities of the Diagnosis and Management of Kawasaki Disease.川崎病诊断与管理的复杂性
Infect Dis Clin North Am. 2015 Sep;29(3):525-37. doi: 10.1016/j.idc.2015.05.006. Epub 2015 Jul 4.
6
Epidemiology, Clinical Presentation, and Outcomes of Kawasaki Disease Among Hospitalized Children in an Inner City Hospital Before and After Publication of the American Academy of Pediatrics/American Heart Association Guidelines for Treatment of Kawasaki Disease: An 11-Year Period.美国儿科学会/美国心脏协会川崎病治疗指南发布前后,一家市中心医院11年间住院儿童川崎病的流行病学、临床表现及转归情况
Clin Pediatr (Phila). 2015 Nov;54(13):1283-9. doi: 10.1177/0009922815592877. Epub 2015 Jul 1.
7
[Present situation and new challenges for medical treatment of Kawasaki disease].[川崎病的医学治疗现状与新挑战]
Nihon Rinsho. 2014 Sep;72(9):1523-9.
8
Kawasaki disease: diagnosis, management, and long-term implications.川崎病:诊断、管理及长期影响
Cardiol Rev. 2007 Jul-Aug;15(4):163-9. doi: 10.1097/CRD.0b013e31802ea93f.
9
Kawasaki disease: part I. Diagnosis, clinical features, and pathogenesis.川崎病:第一部分。诊断、临床特征和发病机制。
J Am Acad Dermatol. 2013 Oct;69(4):501.e1-11; quiz 511-2. doi: 10.1016/j.jaad.2013.07.002.
10
Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications.川崎病药物治疗及其心血管并发症管理的当前建议。
Eur Rev Med Pharmacol Sci. 2007 Sep-Oct;11(5):301-8.

引用本文的文献

1
MIS-C, inherited metabolic diseases and methylmalonic acidemia: a case report and review of the literature.儿童多系统炎症综合征、遗传性代谢疾病与甲基丙二酸血症:一例病例报告及文献综述
Ital J Pediatr. 2025 Jul 1;51(1):202. doi: 10.1186/s13052-025-02052-1.
2
Advancing multidisciplinary management of pediatric hyperinflammatory disorders.推进儿童高炎症性疾病的多学科管理。
Front Pediatr. 2025 Apr 30;13:1553861. doi: 10.3389/fped.2025.1553861. eCollection 2025.
3
[Diagnosis of coronary artery lesions in children based on Z-score regression model].基于Z评分回归模型的儿童冠状动脉病变诊断
Zhongguo Dang Dai Er Ke Za Zhi. 2025 Feb 15;27(2):176-183. doi: 10.7499/j.issn.1008-8830.2405030.
4
[Interpretation of similarities and differences in Kawasaki disease guidelines at home and abroad].[国内外川崎病诊疗指南异同解读]
Zhongguo Dang Dai Er Ke Za Zhi. 2025 Feb 15;27(2):144-147. doi: 10.7499/j.issn.1008-8830.2406041.
5
Expression of Serum Ferritin, Human neutrophil lipocalin, Procalcitonin, and inflammatory factors in children with Kawasaki disease and their relationship to coronary artery lesions.血清铁蛋白、人中性粒细胞脂质运载蛋白、降钙素原及炎症因子在川崎病患儿中的表达及其与冠状动脉病变的关系
Am J Transl Res. 2025 Jan 15;17(1):286-293. doi: 10.62347/MIHQ2583. eCollection 2025.
6
A Case of Refractory Kawasaki Disease With Yersinia pseudotuberculosis Infection Successfully Treated With Cefotaxime Following Immunosuppressive Therapy.1例难治性川崎病合并假结核耶尔森菌感染经免疫抑制治疗后用头孢噻肟成功治愈的病例
Cureus. 2024 Nov 17;16(11):e73866. doi: 10.7759/cureus.73866. eCollection 2024 Nov.
7
Sex- and gender-based medicine in pediatric nutrition.儿科营养中的性别医学。
Ital J Pediatr. 2024 Sep 2;50(1):159. doi: 10.1186/s13052-024-01734-6.
8
Guideline for the diagnosis and treatment of incomplete Kawasaki disease in children in China.中国儿童不完全川崎病诊断与治疗指南。
BMC Pediatr. 2024 Jul 26;24(1):477. doi: 10.1186/s12887-024-04961-2.
9
Hypoplastic and Congenital Absence of Coronary Arteries and Its Correlation with Clinical Implications of Cardiac Circulation: A Systematic Review and Meta-Analysis.冠状动脉发育不全及先天性缺如及其与心脏循环临床意义的相关性:一项系统评价和荟萃分析
J Clin Med. 2024 May 24;13(11):3085. doi: 10.3390/jcm13113085.
10
Retrospective Analysis of Fever in Pediatric Age: Our Experience over the Last 5 Years.小儿发热的回顾性分析:我们过去5年的经验
Children (Basel). 2024 Apr 30;11(5):539. doi: 10.3390/children11050539.

本文引用的文献

1
Evaluation of myocardial deformation in patients with Kawasaki disease using speckle-tracking echocardiography during mid-term follow-up.在中期随访期间使用斑点追踪超声心动图评估川崎病患者的心肌变形。
Cardiol Young. 2017 Sep;27(7):1377-1385. doi: 10.1017/S1047951117000580. Epub 2017 Apr 5.
2
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.川崎病的诊断、治疗和长期管理:美国心脏协会发布的一份面向医疗保健专业人员的科学声明。
Circulation. 2017 Apr 25;135(17):e927-e999. doi: 10.1161/CIR.0000000000000484. Epub 2017 Mar 29.
3
Kawasaki disease and immunisation: Standardised case definition & guidelines for data collection, analysis.川崎病与免疫接种:标准化病例定义及数据收集、分析指南
Vaccine. 2016 Dec 12;34(51):6582-6596. doi: 10.1016/j.vaccine.2016.09.025. Epub 2016 Nov 15.
4
Utility of adenosine stress perfusion CMR to assess paediatric coronary artery disease.腺苷负荷灌注心脏磁共振成像在儿童冠状动脉疾病评估中的应用。
Eur Heart J Cardiovasc Imaging. 2017 May 1;18(8):898-905. doi: 10.1093/ehjci/jew151.
5
Critical Overview of the Risk Scoring Systems to Predict Non-Responsiveness to Intravenous Immunoglobulin in Kawasaki Syndrome.川崎病静脉注射免疫球蛋白无反应风险评分系统的评价综述。
Int J Mol Sci. 2016 Feb 24;17(3):278. doi: 10.3390/ijms17030278.
6
Vaccines and Kawasaki disease.疫苗与川崎病。
Expert Rev Vaccines. 2016;15(3):417-24. doi: 10.1586/14760584.2016.1128329. Epub 2015 Dec 16.
7
The epidemiology of Kawasaki disease: a global update.川崎病的流行病学:全球最新情况
Arch Dis Child. 2015 Nov;100(11):1084-8. doi: 10.1136/archdischild-2014-307536. Epub 2015 Jun 25.
8
PRR-signaling pathways: Learning from microbial tactics.PRR 信号通路:从微生物策略中学习。
Semin Immunol. 2015 Mar;27(2):75-84. doi: 10.1016/j.smim.2015.03.009. Epub 2015 Apr 22.
9
Kawasaki disease: insights into pathogenesis and approaches to treatment.川崎病:发病机制的深入了解和治疗方法。
Nat Rev Rheumatol. 2015 Aug;11(8):475-82. doi: 10.1038/nrrheum.2015.54. Epub 2015 Apr 28.
10
Update of genetic susceptibility in patients with Kawasaki disease.川崎病患者遗传易感性的最新进展。
Korean J Pediatr. 2015 Mar;58(3):84-8. doi: 10.3345/kjp.2015.58.3.84. Epub 2015 Mar 20.

川崎病:意大利儿科学会指南,第一部分-定义、流行病学、病因发病机制、急性期临床表现和治疗。

Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase.

机构信息

Bambino Gesù Children's Hospital, Rome, Italy, Piazza S. Onofrio n. 4, 00165, Rome, Italy.

Fondazione Policlinico Universitario A. Gemelli, Università Cattolica Sacro Cuore, Rome, Italy.

出版信息

Ital J Pediatr. 2018 Aug 30;44(1):102. doi: 10.1186/s13052-018-0536-3.

DOI:10.1186/s13052-018-0536-3
PMID:30157897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6116535/
Abstract

The primary purpose of these practical guidelines related to Kawasaki disease (KD) is to contribute to prompt diagnosis and appropriate treatment on the basis of different specialists' contributions in the field. A set of 40 recommendations is provided, divided in two parts: the first describes the definition of KD, its epidemiology, etiopathogenetic hints, presentation, clinical course and general management, including treatment of the acute phase, through specific 23 recommendations.Their application is aimed at improving the rate of treatment with intravenous immunoglobulin and the overall potential development of coronary artery abnormalities in KD. Guidelines, however, should not be considered a norm that limits treatment options of pediatricians and practitioners, as treatment modalities other than those recommended may be required as a result of peculiar medical circumstances, patient's condition, and disease severity or complications.

摘要

本《川崎病实用指南》的主要目的是在不同领域专家贡献的基础上,促进川崎病的快速诊断和合理治疗。本指南共提供 40 条推荐意见,分为两部分:第一部分描述了川崎病的定义、流行病学、病因发病机制提示、表现、临床病程和一般管理,包括急性期的治疗,通过 23 条具体推荐意见来实现。应用这些推荐意见的目的是提高川崎病患儿接受静脉注射免疫球蛋白治疗的比例,以及整体上降低川崎病冠状动脉异常的发生率。然而,本指南不应被视为限制儿科医生和临床医生治疗选择的规范,因为可能需要根据特殊的医疗情况、患者病情、疾病严重程度或并发症等因素,选择推荐意见以外的治疗方式。